Does it cause high blood pressure?
Xeljanz (tofacitinib citrate) can cause high blood pressure (hypertension) in people with rheumatoid arthritis and psoriatic arthritis.
During clinical development of Xeljanz, hypertension was found to be a common side effect of treatment with the drug, occurring in 2% of patients with rheumatoid and psoriatic arthritis. High blood pressure was observed in 2% patients treated with Xeljanz 5mg twice daily, as well as 2% of patients treated with the higher 10mg twice a day dose.
When they combined data from six phase III studies and two long-term extension studies conducted in patients with rheumatoid arthritis, researchers found that blood pressure remained stable over time and that adverse events related to hypertension were low.
Pooled data from phase III and long-term extension studies conducted in patients with psoriatic arthritis, also showed the incidence of hypertension-related adverse events was low.
Xeljanz is a Janus kinase (JAK) inhibitor used in the treatment of rheumatoid arthritis, psoriatic arthritis, polyarticular course juvenile idiopathic arthritis, ankylosing spondylitis and ulcerative colitis.
Related medical questions
- What happens when you stop taking Xeljanz?
- How long does it take to work?
- Can I drink alcohol while taking Xeljanz?
- What is it used for and is it a biologic?
- Does it cause hair loss?
- Can you take Xeljanz with antibiotics and antifungals?
- Does it cause weight gain?
- Does it cause high blood pressure?
- Is Xeljanz approved for ankylosing spondylitis?
- What are JAK inhibitors and how do they work?
- What happens when you stop taking Xeljanz?
- Which JAK inhibitors are approved in the U.S?
- How long does it take to work?
- Can I drink alcohol while taking Xeljanz?
- What is it used for and is it a biologic?
- Does it cause hair loss?
- Can you take Xeljanz with antibiotics and antifungals?
- Does it cause weight gain?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions